EQS-News: Mutares has completed the acquisition of Alcura France from Alliance Healthcare Group France
|
EQS-News: Mutares SE & Co. KGaA
/ Key word(s): Investment/Takeover
Mutares has completed the acquisition of Alcura France from Alliance Healthcare Group France
Munich, December 18, 2024 – Mutares SE & Co. KGaA (ISIN: DE000A2NB650) has completed the acquisition of Alcura France from Alliance Healthcare Group France. The company is headquartered in Châteauroux, France, and is a specialised distributor of home care solutions. Established in 1973, Alcura France is a key player in the distribution of home care solutions in France, servicing a diversified customer base of more than 8,000 active customers. The company is specialized in providing medical equipment to seniors, individuals with disabilities, and other patients, and has distinguished itself through a wide offering of products, encompassing more than 3,000 referenced products, from medical beds to breast pumps and wheelchairs. With a workforce of approx. 500 professionals with proven medical expertise, distributed across 43 agencies in France, Alcura France generated revenues of around EUR 60 million in 2023. Company profile of Mutares SE & Co. KGaA Mutares SE & Co. KGaA, Munich (www.mutares.com), a listed private equity holding company with offices in Munich (HQ), Amsterdam, Bad Wiessee, Chicago, Frankfurt, Helsinki, London, Madrid, Milan, Mumbai, Paris, Shanghai, Stockholm, Vienna and Warsaw, acquires companies in special situations which show significant operational improvement potential and are sold again after undergoing a repositioning and stabilization process. For the fiscal year 2024, consolidated revenues of EUR 5.7 billion to EUR 6.3 billion are expected. Based on this, consolidated revenues are to be expanded to approx. EUR 7 billion by 2025 and EUR 10 billion by 2028. As the portfolio grows, so do consulting revenues, which together with portfolio dividends and exit proceeds accrue to the Mutares Holding. On this basis, the Holding Company is expected to generate a net income of EUR 108 million to EUR 132 million for the fiscal year 2024, EUR 125 million to EUR 150 million for the fiscal year 2025 and EUR 200 million for the fiscal year 2028. The Management Board and Supervisory Board together hold more than one-third of all Mutares shares with voting rights. The shares of Mutares SE & Co. KGaA are traded on the Regulated Market of the Frankfurt Stock Exchange under the symbol "MUX" (ISIN: DE000A2NB650) and have been part of the selection index SDAX since December 2023. For more information, please contact: Mutares SE & Co. KGaA Press Contact in Germany Press Contact in France Press Contact in UK
18.12.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | Mutares SE & Co. KGaA |
| Arnulfstr.19 | |
| 80335 Munich | |
| Germany | |
| Phone: | +49 (0)89-9292 776-0 |
| Fax: | +49 (0)89-9292 776-22 |
| E-mail: | ir@mutares.de |
| Internet: | www.mutares.de |
| ISIN: | DE000A2NB650 |
| WKN: | A2NB65 |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2049121 |
| End of News | EQS News Service |
|
|
2049121 18.12.2024 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024e | ||
| Sales1 | 865,10 | 1.015,90 | 1.583,90 | 2.504,00 | 3.751,70 | 4.689,10 | 0,00 | |
| EBITDA1,2 | 49,10 | 79,20 | 142,70 | 566,50 | 181,50 | 756,90 | 0,00 | |
| EBITDA-Margin3 | 5,68 | 7,80 | 9,01 | 22,62 | 4,84 | 16,14 | 0,00 | |
| EBIT1,4 | 19,40 | 26,20 | 41,20 | 447,30 | -3,10 | 436,90 | 0,00 | |
| EBIT-Margin5 | 2,24 | 2,58 | 2,60 | 17,86 | -0,08 | 9,32 | 0,00 | |
| Net Profit (Loss)1 | 12,00 | 16,70 | 19,70 | 442,40 | -21,00 | 367,10 | 0,00 | |
| Net-Margin6 | 1,39 | 1,64 | 1,24 | 17,67 | -0,56 | 7,83 | 0,00 | |
| Cashflow1,7 | -11,10 | -10,70 | -43,00 | -103,50 | -20,80 | -27,50 | 0,00 | |
| Earnings per share8 | 0,96 | 1,37 | 1,78 | 26,83 | -0,32 | 18,41 | 2,70 | |
| Dividend per share8 | 1,00 | 1,00 | 1,50 | 1,50 | 1,75 | 2,25 | 2,00 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: Deloitte
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Mutares | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| A2NB65 | DE000A2NB650 | SE & Co. KGaA | 515,56 Mio € | 10.06.2008 | Kaufen | 8FWH4HV2+3M |
| PE 2025e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 7,67 | 10,58 | 0,72 | 4,42 | 0,50 | -18,75 | 0,11 |
|
Dividend '2022 in € |
Dividend '2023 in € |
Dividend '2024e in € |
Div.-Yield '2024e in % |
| 1,75 | 2,25 | 2,00 | 8,28% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 06.06.2025 | 15.05.2025 | 12.08.2025 | 07.11.2024 | 29.04.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +2,03% | -23,67% | -31,78% | -31,59% | +82,13% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
